首页> 美国卫生研究院文献>Oncology Letters >Current status of submucosal tunneling endoscopic resection for gastrointestinal submucosal tumors originating from the muscularis propria layer
【2h】

Current status of submucosal tunneling endoscopic resection for gastrointestinal submucosal tumors originating from the muscularis propria layer

机译:固有肌层引起的胃肠道黏膜下肿瘤的黏膜下隧道内镜切除术现状

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gastrointestinal submucosal tumors (SMTs) have been increasingly identified via the use of endoscopic ultrasonography, and removal is often recommended for SMTs that are >2 cm in diameter or symptomatic. Submucosal tunneling endoscopic resection (STER), also known as submucosal endoscopic tumor resection, endoscopic submucosal tunnel dissection or tunneling endoscopic muscularis dissection, is a novel endoscopic technique for treating gastrointestinal SMTs originating from the muscularis propria layer, and has been demonstrated to be effective in the removal of SMTs with a decreased rate of recurrence by clinical studies. STER may be performed for patients with esophageal or cardia SMTs, and its application has expanded beyond these types of SMTs due to modifications to the technique. The present study reviewed the applications, procedure, efficacy and complications associated with STER.
机译:通过使用内窥镜超声检查越来越多地发现了胃肠道粘膜下肿瘤(SMT),对于直径> 2 cm或有症状的SMT,通常建议切除。黏膜下隧道内镜切除术(STER),也称为黏膜下内镜肿瘤切除术,内镜下黏膜下隧道解剖或隧道内镜下肌瘤剥离术,是一种新型的内窥镜技术,用于治疗源自固有肌层的胃肠道SMT,并已被证明可有效治疗通过临床研究去除具有降低复发率的SMT。可以对食管或card门SMT患者进行STER,由于对技术的改进,其应用范围已扩展到这些类型的SMT之外。本研究回顾了与STER相关的应用,程序,疗效和并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号